Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Cabaletta Bio Inc (NASDAQ: CABA) closed at $1.63 in the last session, up 1.87% from day before closing price of $1.6. In other words, the price has increased by $1.87 from its previous closing price. On the day, 0.93 million shares were traded. CABA stock price reached its highest trading level at $1.63 during the session, while it also had its lowest trading level at $1.56.
Ratios:
We take a closer look at CABA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.96 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 20, 2024, Downgraded its rating to In-line and sets its target price to $6 from $15 previously.
On December 19, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $6.
On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $10.UBS initiated its Buy rating on October 10, 2024, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 146607264 and an Enterprise Value of -25907486.
Stock Price History:
The Beta on a monthly basis for CABA is 2.74, which has changed by -0.7843915 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $8.77, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -3.20%, while the 200-Day Moving Average is calculated to be -34.97%.
Shares Statistics:
According to the various share statistics, CABA traded on average about 2.04M shares per day over the past 3-months and 2270520 shares per day over the past 10 days. A total of 89.94M shares are outstanding, with a floating share count of 81.83M. Insiders hold about 9.03% of the company’s shares, while institutions hold 43.66% stake in the company. Shares short for CABA as of 1749772800 were 6465638 with a Short Ratio of 3.17, compared to 1747267200 on 5523704. Therefore, it implies a Short% of Shares Outstanding of 6465638 and a Short% of Float of 7.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of Cabaletta Bio Inc (CABA) involves the perspectives of 6.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.35 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$1.38 and -$3.2 for the fiscal current year, implying an average EPS of -$2.35. EPS for the following year is -$2.11, with 6.0 analysts recommending between -$0.95 and -$3.11.
